Globus Medical, Inc.
Globus Medical, Inc. (GMED) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GMED · as of Jun 8, 2026
Key Statistics
Explore Globus Medical, Inc. Data
gmed stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 36 · Buy rate: 75.0%
The GMED analyst consensus is Buy, based on ratings from 36 Wall Street analysts over the past 3 months. The average 12-month price target is $110.29, representing +37.86% upside from the current price of $80.00.
Competitors & Peers
gmed competitorsGMED
ALGN
ATR
BIO
DVA
GRFSStock Performance
Full HistoryAbout Globus Medical, Inc.
Globus Medical, Inc. a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine p…
what is globus medical, inc. · gmed stock overview · globus medical, inc. company profile · who is globus medical, inc. ceo · gmed NYSE · globus medical, inc. headquarters · globus medical, inc. business segments
About Stock Overview & Key Data
Globus Medical, Inc. (GMED) is a Healthcare company in the Medical - Devices industry, listed on NYSE since Aug 3, 2012. As of the latest trading session, GMED stock price is $80.00, with a market capitalization of $10.8B. The stock has returned +32.58% over the past 12 months and -8.37% year-to-date.
According to 36 Wall Street analysts, the consensus rating for Globus Medical, Inc. stock is Buy, with an average 12-month price target of $110.29. In fiscal year 2025, Globus Medical, Inc. reported revenue of $2.9B and net income of $537.9M. For detailed data — including Globus Medical, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Globus Medical, Inc. (GMED) stock price is $80.00. The stock is traded on NYSE under the ticker symbol GMED. The 52-week range is $51.79 – $101.40.